Prevalence of osteoporosis and the use of bone protective therapies in dermatology clinic patients on long-term glucocorticoids-Reference-Cited by-同舟云学术

Prevalence of osteoporosis and the use of bone protective therapies in dermatology clinic patients on long-term glucocorticoids

Published:2015-04-22 Issue:2 Volume:56 Page:147-148
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australasian Journal of Dermatology

Author:

Abell Sally¹,Zeimer Howard¹,Chong Alvin²,MacIsaac Richard J¹³

Affiliation:

1. Department of Endocrinology; St Vincent's Hospital; Melbourne Victoria Australia

2. Department of Dermatology; St Vincent's Hospital; Melbourne Victoria Australia

3. University of Melbourne; Melbourne Victoria Australia

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12164/fullpdf

Reference4 articles.

1. Glucocorticoid induced bone disease;Weinstein;N. Engl. J. Med.,2011

2. Glucocorticoid-induced bone loss in dermatologic patients: an update;Sumney;Arch. Dermatol.,2006

3. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy;Von Staa;Arthritis Rheum.,2003

4. Multifaceted educational program increases prescribing of preventative medication for corticosteroid induced osteoporosis;Naunton;J. Rheumatol.,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional HDAC6 pathway;Journal of Cell Science;2020-01-01

2. High-throughput metabolomics investigates anti-osteoporosis activity of oleanolic acid via regulating metabolic networks using ultra-performance liquid chromatography coupled with mass spectrometry;Phytomedicine;2018-12

3. LC-MS-based plasma metabolomics reveals metabolic variations in ovariectomy-induced osteoporosis in female Wistar rats;RSC Advances;2018